|
|
Volumn 22, Issue 8, 2002, Pages 1074-1076
|
|
Promising microbicide approach for prevention of human immunodeficiency virus transmission needs more support
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
BUFFER;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MONOCLONAL ANTIBODY;
NONOXINOL 9;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SURFACTANT;
NONOXINOL;
TOPICAL ANTIINFECTIVE AGENT;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
CONDOM;
CONTRACEPTION;
DRUG FORMULATION;
DRUG MARKETING;
EPIDEMIC;
GENITAL SYSTEM;
HEALTH CARE ORGANIZATION;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
INFECTION PREVENTION;
SEXUAL BEHAVIOR;
SHORT SURVEY;
VIRUS ADSORPTION;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
DISEASE TRANSMISSION;
DRUG EFFECT;
FEMALE;
GEL;
INTERNATIONAL COOPERATION;
INTRAVAGINAL DRUG ADMINISTRATION;
REVIEW;
SEXUALLY TRANSMITTED DISEASE;
ADMINISTRATION, INTRAVAGINAL;
ANTI-INFECTIVE AGENTS, LOCAL;
CONDOMS, FEMALE;
FEMALE;
GELS;
HIV;
HIV INFECTIONS;
HUMANS;
INTERNATIONAL COOPERATION;
NONOXYNOL;
SEXUALLY TRANSMITTED DISEASES, VIRAL;
|
|
EID: 0036021229
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.22.12.1074.33610 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (13)
|
